nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—SRMS—gall bladder—sclerosing cholangitis	0.0219	0.0386	CbGeAlD
Bosutinib—STK26—gall bladder—sclerosing cholangitis	0.0207	0.0364	CbGeAlD
Bosutinib—CLK3—pancreas—sclerosing cholangitis	0.0106	0.0186	CbGeAlD
Bosutinib—VRK2—pancreas—sclerosing cholangitis	0.0099	0.0174	CbGeAlD
Bosutinib—STK26—pancreas—sclerosing cholangitis	0.00953	0.0168	CbGeAlD
Bosutinib—WEE1—pancreas—sclerosing cholangitis	0.00913	0.0161	CbGeAlD
Bosutinib—STK25—pancreas—sclerosing cholangitis	0.00871	0.0154	CbGeAlD
Bosutinib—PLK2—pancreas—sclerosing cholangitis	0.00847	0.0149	CbGeAlD
Bosutinib—CAMK1D—pancreas—sclerosing cholangitis	0.008	0.0141	CbGeAlD
Bosutinib—PDGFRB—gall bladder—sclerosing cholangitis	0.0073	0.0129	CbGeAlD
Bosutinib—TLK1—liver—sclerosing cholangitis	0.00726	0.0128	CbGeAlD
Bosutinib—PRKCQ—liver—sclerosing cholangitis	0.00716	0.0126	CbGeAlD
Bosutinib—SIK2—liver—sclerosing cholangitis	0.00707	0.0124	CbGeAlD
Bosutinib—FRK—liver—sclerosing cholangitis	0.00689	0.0121	CbGeAlD
Bosutinib—CLK3—liver—sclerosing cholangitis	0.00672	0.0118	CbGeAlD
Bosutinib—MAP4K4—pancreas—sclerosing cholangitis	0.0066	0.0116	CbGeAlD
Bosutinib—CASK—liver—sclerosing cholangitis	0.00657	0.0116	CbGeAlD
Bosutinib—NUAK2—pancreas—sclerosing cholangitis	0.00656	0.0116	CbGeAlD
Bosutinib—EIF2AK1—liver—sclerosing cholangitis	0.0065	0.0114	CbGeAlD
Bosutinib—STK35—pancreas—sclerosing cholangitis	0.00638	0.0112	CbGeAlD
Bosutinib—CSK—pancreas—sclerosing cholangitis	0.00634	0.0112	CbGeAlD
Bosutinib—FES—liver—sclerosing cholangitis	0.0063	0.0111	CbGeAlD
Bosutinib—VRK2—liver—sclerosing cholangitis	0.0063	0.0111	CbGeAlD
Bosutinib—CSNK1A1—pancreas—sclerosing cholangitis	0.00629	0.0111	CbGeAlD
Bosutinib—CLK1—pancreas—sclerosing cholangitis	0.00625	0.011	CbGeAlD
Bosutinib—TNIK—liver—sclerosing cholangitis	0.00618	0.0109	CbGeAlD
Bosutinib—CAMK2G—pancreas—sclerosing cholangitis	0.00614	0.0108	CbGeAlD
Bosutinib—CDK2—liver—sclerosing cholangitis	0.00612	0.0108	CbGeAlD
Bosutinib—STK26—liver—sclerosing cholangitis	0.00606	0.0107	CbGeAlD
Bosutinib—CSNK1E—pancreas—sclerosing cholangitis	0.00583	0.0103	CbGeAlD
Bosutinib—WEE1—liver—sclerosing cholangitis	0.00581	0.0102	CbGeAlD
Bosutinib—DMPK—liver—sclerosing cholangitis	0.00581	0.0102	CbGeAlD
Bosutinib—SIK1—pancreas—sclerosing cholangitis	0.00574	0.0101	CbGeAlD
Bosutinib—ERBB3—pancreas—sclerosing cholangitis	0.00563	0.00992	CbGeAlD
Bosutinib—MAP2K2—pancreas—sclerosing cholangitis	0.00562	0.00989	CbGeAlD
Bosutinib—STK25—liver—sclerosing cholangitis	0.00554	0.00977	CbGeAlD
Bosutinib—PTK2—pancreas—sclerosing cholangitis	0.00546	0.00962	CbGeAlD
Bosutinib—TBK1—pancreas—sclerosing cholangitis	0.00546	0.00962	CbGeAlD
Bosutinib—PLK2—liver—sclerosing cholangitis	0.00539	0.0095	CbGeAlD
Bosutinib—SIK3—liver—sclerosing cholangitis	0.00535	0.00944	CbGeAlD
Bosutinib—IRAK1—pancreas—sclerosing cholangitis	0.00535	0.00943	CbGeAlD
Bosutinib—RPS6KB1—pancreas—sclerosing cholangitis	0.00525	0.00925	CbGeAlD
Bosutinib—STK4—liver—sclerosing cholangitis	0.00515	0.00908	CbGeAlD
Bosutinib—CAMK1D—liver—sclerosing cholangitis	0.00509	0.00897	CbGeAlD
Bosutinib—STK24—liver—sclerosing cholangitis	0.00503	0.00887	CbGeAlD
Bosutinib—SLK—pancreas—sclerosing cholangitis	0.005	0.00882	CbGeAlD
Bosutinib—EPHB4—pancreas—sclerosing cholangitis	0.00497	0.00876	CbGeAlD
Bosutinib—EPHA2—pancreas—sclerosing cholangitis	0.00487	0.00859	CbGeAlD
Bosutinib—FER—liver—sclerosing cholangitis	0.00487	0.00858	CbGeAlD
Bosutinib—LYN—liver—sclerosing cholangitis	0.00485	0.00854	CbGeAlD
Bosutinib—MAP4K5—pancreas—sclerosing cholangitis	0.00476	0.00838	CbGeAlD
Bosutinib—BTK—liver—sclerosing cholangitis	0.00475	0.00837	CbGeAlD
Bosutinib—TNK2—liver—sclerosing cholangitis	0.00468	0.00825	CbGeAlD
Bosutinib—MAP4K2—liver—sclerosing cholangitis	0.00462	0.00813	CbGeAlD
Bosutinib—STK3—liver—sclerosing cholangitis	0.00455	0.00802	CbGeAlD
Bosutinib—ROCK1—liver—sclerosing cholangitis	0.00449	0.00792	CbGeAlD
Bosutinib—YES1—pancreas—sclerosing cholangitis	0.00439	0.00774	CbGeAlD
Bosutinib—BMPR2—liver—sclerosing cholangitis	0.00437	0.00769	CbGeAlD
Bosutinib—TAOK3—pancreas—sclerosing cholangitis	0.00434	0.00764	CbGeAlD
Bosutinib—STK36—liver—sclerosing cholangitis	0.00433	0.00763	CbGeAlD
Bosutinib—MERTK—liver—sclerosing cholangitis	0.00428	0.00754	CbGeAlD
Bosutinib—SRC—pancreas—sclerosing cholangitis	0.00422	0.00744	CbGeAlD
Bosutinib—MAP4K4—liver—sclerosing cholangitis	0.0042	0.0074	CbGeAlD
Bosutinib—NUAK2—liver—sclerosing cholangitis	0.00417	0.00735	CbGeAlD
Bosutinib—BCR—liver—sclerosing cholangitis	0.00417	0.00735	CbGeAlD
Bosutinib—MAP3K12—liver—sclerosing cholangitis	0.00414	0.0073	CbGeAlD
Bosutinib—MAP2K1—liver—sclerosing cholangitis	0.00406	0.00715	CbGeAlD
Bosutinib—STK35—liver—sclerosing cholangitis	0.00406	0.00715	CbGeAlD
Bosutinib—CSK—liver—sclerosing cholangitis	0.00403	0.0071	CbGeAlD
Bosutinib—CSNK1A1—liver—sclerosing cholangitis	0.00401	0.00706	CbGeAlD
Bosutinib—HCK—liver—sclerosing cholangitis	0.00398	0.00701	CbGeAlD
Bosutinib—CLK1—liver—sclerosing cholangitis	0.00398	0.00701	CbGeAlD
Bosutinib—ABL2—liver—sclerosing cholangitis	0.00395	0.00697	CbGeAlD
Bosutinib—CAMK2G—liver—sclerosing cholangitis	0.00391	0.00688	CbGeAlD
Bosutinib—BMP2K—liver—sclerosing cholangitis	0.00391	0.00688	CbGeAlD
Bosutinib—LRRK2—liver—sclerosing cholangitis	0.00387	0.00682	CbGeAlD
Bosutinib—EGFR—liver—sclerosing cholangitis	0.00386	0.0068	CbGeAlD
Bosutinib—PTK2B—liver—sclerosing cholangitis	0.00377	0.00665	CbGeAlD
Bosutinib—CSNK1E—liver—sclerosing cholangitis	0.00371	0.00654	CbGeAlD
Bosutinib—SIK1—liver—sclerosing cholangitis	0.00365	0.00644	CbGeAlD
Bosutinib—IRAK4—liver—sclerosing cholangitis	0.00365	0.00644	CbGeAlD
Bosutinib—ERBB3—liver—sclerosing cholangitis	0.00358	0.00631	CbGeAlD
Bosutinib—MAP2K2—liver—sclerosing cholangitis	0.00357	0.0063	CbGeAlD
Bosutinib—ULK3—liver—sclerosing cholangitis	0.00357	0.0063	CbGeAlD
Bosutinib—MAP3K2—liver—sclerosing cholangitis	0.00355	0.00625	CbGeAlD
Bosutinib—MAP3K7—liver—sclerosing cholangitis	0.00351	0.00619	CbGeAlD
Bosutinib—TBK1—liver—sclerosing cholangitis	0.00347	0.00612	CbGeAlD
Bosutinib—PTK2—liver—sclerosing cholangitis	0.00347	0.00612	CbGeAlD
Bosutinib—IRAK1—liver—sclerosing cholangitis	0.00341	0.006	CbGeAlD
Bosutinib—PDGFRB—pancreas—sclerosing cholangitis	0.00336	0.00593	CbGeAlD
Bosutinib—RPS6KB1—liver—sclerosing cholangitis	0.00334	0.00589	CbGeAlD
Bosutinib—FGR—liver—sclerosing cholangitis	0.00332	0.00585	CbGeAlD
Bosutinib—LCK—liver—sclerosing cholangitis	0.00332	0.00585	CbGeAlD
Bosutinib—AXL—liver—sclerosing cholangitis	0.00331	0.00583	CbGeAlD
Bosutinib—SLK—liver—sclerosing cholangitis	0.00318	0.00561	CbGeAlD
Bosutinib—EPHB4—liver—sclerosing cholangitis	0.00316	0.00557	CbGeAlD
Bosutinib—EPHA2—liver—sclerosing cholangitis	0.0031	0.00546	CbGeAlD
Bosutinib—FYN—liver—sclerosing cholangitis	0.0031	0.00546	CbGeAlD
Bosutinib—MAP3K3—liver—sclerosing cholangitis	0.00303	0.00533	CbGeAlD
Bosutinib—MAP4K5—liver—sclerosing cholangitis	0.00303	0.00533	CbGeAlD
Bosutinib—ABL1—pancreas—sclerosing cholangitis	0.003	0.00528	CbGeAlD
Bosutinib—YES1—liver—sclerosing cholangitis	0.00279	0.00492	CbGeAlD
Bosutinib—STK10—liver—sclerosing cholangitis	0.00277	0.00488	CbGeAlD
Bosutinib—TAOK3—liver—sclerosing cholangitis	0.00276	0.00486	CbGeAlD
Bosutinib—SRC—liver—sclerosing cholangitis	0.00269	0.00474	CbGeAlD
Bosutinib—MAP2K5—liver—sclerosing cholangitis	0.00247	0.00436	CbGeAlD
Bosutinib—CSF1R—liver—sclerosing cholangitis	0.00241	0.00425	CbGeAlD
Bosutinib—PDGFRB—liver—sclerosing cholangitis	0.00214	0.00377	CbGeAlD
Bosutinib—ABL1—p73 transcription factor network—BCL2L11—sclerosing cholangitis	0.00209	0.00483	CbGpPWpGaD
Bosutinib—PHKG1—Carbohydrate metabolism—GOT1—sclerosing cholangitis	0.00207	0.00479	CbGpPWpGaD
Bosutinib—SRC—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.00206	0.00477	CbGpPWpGaD
Bosutinib—RPS6KB1—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00206	0.00476	CbGpPWpGaD
Bosutinib—MAP2K5—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00206	0.00476	CbGpPWpGaD
Bosutinib—ROCK1—Apoptosis—BCL2L11—sclerosing cholangitis	0.00201	0.00466	CbGpPWpGaD
Bosutinib—IRAK4—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00198	0.00457	CbGpPWpGaD
Bosutinib—PTK2B—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00196	0.00452	CbGpPWpGaD
Bosutinib—MAP3K7—DNA Damage Response (only ATM dependent)—BCL2L11—sclerosing cholangitis	0.00194	0.00449	CbGpPWpGaD
Bosutinib—ABL1—liver—sclerosing cholangitis	0.00191	0.00336	CbGeAlD
Bosutinib—EGFR—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00182	0.0042	CbGpPWpGaD
Bosutinib—RPS6KB1—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00182	0.0042	CbGpPWpGaD
Bosutinib—MAP2K5—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00182	0.0042	CbGpPWpGaD
Bosutinib—SIK1—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.0018	0.00417	CbGpPWpGaD
Bosutinib—IRAK4—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.0018	0.00416	CbGpPWpGaD
Bosutinib—PTK2B—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00178	0.00412	CbGpPWpGaD
Bosutinib—MAP2K1—Corticotropin-releasing hormone—TCF4—sclerosing cholangitis	0.00175	0.00404	CbGpPWpGaD
Bosutinib—EPHA2—NRF2 pathway—GGT1—sclerosing cholangitis	0.00172	0.00398	CbGpPWpGaD
Bosutinib—ROCK1—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.0017	0.00392	CbGpPWpGaD
Bosutinib—SRC—Angiogenesis—HIF1A—sclerosing cholangitis	0.00168	0.00389	CbGpPWpGaD
Bosutinib—PTK2—Apoptosis—BCL2L11—sclerosing cholangitis	0.00166	0.00385	CbGpPWpGaD
Bosutinib—ABL1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00163	0.00378	CbGpPWpGaD
Bosutinib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00162	0.00376	CbGpPWpGaD
Bosutinib—ABL1—DNA Damage Response (only ATM dependent)—BCL2L11—sclerosing cholangitis	0.00161	0.00373	CbGpPWpGaD
Bosutinib—MAP2K1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00161	0.00372	CbGpPWpGaD
Bosutinib—EPHA4—Spinal Cord Injury—NOS2—sclerosing cholangitis	0.00158	0.00366	CbGpPWpGaD
Bosutinib—SRC—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00155	0.00359	CbGpPWpGaD
Bosutinib—ROCK1—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.00154	0.00357	CbGpPWpGaD
Bosutinib—TNIK—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.00153	0.00353	CbGpPWpGaD
Bosutinib—SRC—Alpha9 beta1 integrin signaling events—NOS2—sclerosing cholangitis	0.00148	0.00342	CbGpPWpGaD
Bosutinib—EPHB3—Developmental Biology—TCF4—sclerosing cholangitis	0.00147	0.0034	CbGpPWpGaD
Bosutinib—LOC400927-CSNK1E—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.00147	0.0034	CbGpPWpGaD
Bosutinib—EGFR—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.0014	0.00323	CbGpPWpGaD
Bosutinib—FES—Developmental Biology—TCF4—sclerosing cholangitis	0.00138	0.0032	CbGpPWpGaD
Bosutinib—FGR—Platelet homeostasis—NOS2—sclerosing cholangitis	0.00136	0.00315	CbGpPWpGaD
Bosutinib—MAP2K2—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00136	0.00314	CbGpPWpGaD
Bosutinib—EPHA5—Developmental Biology—TCF4—sclerosing cholangitis	0.00131	0.00303	CbGpPWpGaD
Bosutinib—EPHA3—Developmental Biology—TCF4—sclerosing cholangitis	0.00131	0.00303	CbGpPWpGaD
Bosutinib—ABL2—Developmental Biology—TCF4—sclerosing cholangitis	0.00131	0.00303	CbGpPWpGaD
Bosutinib—ERBB4—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.0013	0.003	CbGpPWpGaD
Bosutinib—FYN—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00128	0.00296	CbGpPWpGaD
Bosutinib—MAP2K1—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00127	0.00294	CbGpPWpGaD
Bosutinib—EPHA8—Developmental Biology—TCF4—sclerosing cholangitis	0.00127	0.00293	CbGpPWpGaD
Bosutinib—PTK2—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00126	0.00291	CbGpPWpGaD
Bosutinib—EPHB4—Developmental Biology—TCF4—sclerosing cholangitis	0.00125	0.00289	CbGpPWpGaD
Bosutinib—EPHA4—Developmental Biology—TCF4—sclerosing cholangitis	0.00125	0.00289	CbGpPWpGaD
Bosutinib—CDK2—Spinal Cord Injury—NOS2—sclerosing cholangitis	0.00124	0.00287	CbGpPWpGaD
Bosutinib—EPHB2—Developmental Biology—TCF4—sclerosing cholangitis	0.00121	0.0028	CbGpPWpGaD
Bosutinib—MAP4K4—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.00121	0.00279	CbGpPWpGaD
Bosutinib—MAP2K2—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.0012	0.00277	CbGpPWpGaD
Bosutinib—PHKG1—Metabolism—ABCB4—sclerosing cholangitis	0.0012	0.00277	CbGpPWpGaD
Bosutinib—SRC—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00119	0.00276	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00119	0.00275	CbGpPWpGaD
Bosutinib—PRKCQ—Developmental Biology—TCF4—sclerosing cholangitis	0.00115	0.00267	CbGpPWpGaD
Bosutinib—ERBB3—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00115	0.00265	CbGpPWpGaD
Bosutinib—FYN—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00113	0.00261	CbGpPWpGaD
Bosutinib—MAP2K1—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00112	0.00259	CbGpPWpGaD
Bosutinib—MAP2K2—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00109	0.00253	CbGpPWpGaD
Bosutinib—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00106	0.00245	CbGpPWpGaD
Bosutinib—MAP2K1—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00102	0.00236	CbGpPWpGaD
Bosutinib—EPHA2—Developmental Biology—TCF4—sclerosing cholangitis	0.00102	0.00236	CbGpPWpGaD
Bosutinib—MERTK—Hemostasis—NOS2—sclerosing cholangitis	0.00101	0.00234	CbGpPWpGaD
Bosutinib—MAP2K1—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00101	0.00233	CbGpPWpGaD
Bosutinib—IRAK1—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.000954	0.00221	CbGpPWpGaD
Bosutinib—SRC—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.000942	0.00218	CbGpPWpGaD
Bosutinib—ABCB1—pancreas—sclerosing cholangitis	0.000932	0.00164	CbGeAlD
Bosutinib—MAP2K1—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.000918	0.00212	CbGpPWpGaD
Bosutinib—LCK—Notch Signaling Pathway—HIF1A—sclerosing cholangitis	0.0009	0.00208	CbGpPWpGaD
Bosutinib—STK4—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000887	0.00205	CbGpPWpGaD
Bosutinib—EGFR—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.000877	0.00203	CbGpPWpGaD
Bosutinib—CYP3A4—liver—sclerosing cholangitis	0.000838	0.00148	CbGeAlD
Bosutinib—SRC—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.000831	0.00192	CbGpPWpGaD
Bosutinib—LCK—IL12-mediated signaling events—NOS2—sclerosing cholangitis	0.00083	0.00192	CbGpPWpGaD
Bosutinib—EGFR—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.000798	0.00184	CbGpPWpGaD
Bosutinib—SRC—Notch Signaling Pathway—HIF1A—sclerosing cholangitis	0.000797	0.00184	CbGpPWpGaD
Bosutinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.000788	0.00182	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.000785	0.00181	CbGpPWpGaD
Bosutinib—CSNK1E—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.000771	0.00178	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.000766	0.00177	CbGpPWpGaD
Bosutinib—ROCK1—Developmental Biology—TCF4—sclerosing cholangitis	0.000765	0.00177	CbGpPWpGaD
Bosutinib—SRC—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.000757	0.00175	CbGpPWpGaD
Bosutinib—STK3—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000754	0.00174	CbGpPWpGaD
Bosutinib—SRC—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.000748	0.00173	CbGpPWpGaD
Bosutinib—FYN—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.000738	0.00171	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.000734	0.0017	CbGpPWpGaD
Bosutinib—CAMK2G—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.000718	0.00166	CbGpPWpGaD
Bosutinib—CDK2—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.000718	0.00166	CbGpPWpGaD
Bosutinib—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.000705	0.00163	CbGpPWpGaD
Bosutinib—SRC—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.00068	0.00157	CbGpPWpGaD
Bosutinib—PHKG1—Disease—GOT2—sclerosing cholangitis	0.00068	0.00157	CbGpPWpGaD
Bosutinib—SRC—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.000672	0.00155	CbGpPWpGaD
Bosutinib—EGFR—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.000638	0.00147	CbGpPWpGaD
Bosutinib—PTK2—Developmental Biology—TCF4—sclerosing cholangitis	0.000633	0.00146	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000632	0.00146	CbGpPWpGaD
Bosutinib—YES1—Developmental Biology—TCF4—sclerosing cholangitis	0.000624	0.00144	CbGpPWpGaD
Bosutinib—LCK—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.000615	0.00142	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000599	0.00139	CbGpPWpGaD
Bosutinib—ABCB1—liver—sclerosing cholangitis	0.000593	0.00105	CbGeAlD
Bosutinib—WEE1—Hemostasis—NOS2—sclerosing cholangitis	0.000591	0.00137	CbGpPWpGaD
Bosutinib—PHKG1—Disease—GOT1—sclerosing cholangitis	0.000587	0.00136	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000572	0.00132	CbGpPWpGaD
Bosutinib—PHKG1—Metabolism—GOT2—sclerosing cholangitis	0.000569	0.00132	CbGpPWpGaD
Bosutinib—BCR—Disease—GOT2—sclerosing cholangitis	0.000554	0.00128	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000548	0.00127	CbGpPWpGaD
Bosutinib—SRC—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.000544	0.00126	CbGpPWpGaD
Bosutinib—EGFR—Spinal Cord Injury—NOS2—sclerosing cholangitis	0.000501	0.00116	CbGpPWpGaD
Bosutinib—PHKG1—Metabolism—GOT1—sclerosing cholangitis	0.000491	0.00114	CbGpPWpGaD
Bosutinib—PHKG1—Metabolism—GGT1—sclerosing cholangitis	0.000491	0.00114	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—TCF4—sclerosing cholangitis	0.000487	0.00113	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000479	0.00111	CbGpPWpGaD
Bosutinib—BCR—Disease—GOT1—sclerosing cholangitis	0.000478	0.00111	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—TCF4—sclerosing cholangitis	0.000465	0.00108	CbGpPWpGaD
Bosutinib—SYK—Hemostasis—NOS2—sclerosing cholangitis	0.000465	0.00107	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—TCF4—sclerosing cholangitis	0.000463	0.00107	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—TCF4—sclerosing cholangitis	0.000458	0.00106	CbGpPWpGaD
Bosutinib—PRKCQ—Hemostasis—NOS2—sclerosing cholangitis	0.000456	0.00105	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—TCF4—sclerosing cholangitis	0.000456	0.00105	CbGpPWpGaD
Bosutinib—ABCB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.000443	0.00102	CbGpPWpGaD
Bosutinib—CSK—Hemostasis—NOS2—sclerosing cholangitis	0.000441	0.00102	CbGpPWpGaD
Bosutinib—PHKG1—Disease—HIF1A—sclerosing cholangitis	0.000408	0.000944	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000407	0.000942	CbGpPWpGaD
Bosutinib—CSNK1A1—Disease—GOT2—sclerosing cholangitis	0.000404	0.000935	CbGpPWpGaD
Bosutinib—PRKCQ—Disease—GOT2—sclerosing cholangitis	0.000404	0.000935	CbGpPWpGaD
Bosutinib—ABCB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.000403	0.000931	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.0004	0.000924	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.0004	0.000924	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—TCF4—sclerosing cholangitis	0.000396	0.000915	CbGpPWpGaD
Bosutinib—CSK—Disease—GOT2—sclerosing cholangitis	0.00039	0.000903	CbGpPWpGaD
Bosutinib—CDK2—Hemostasis—NOS2—sclerosing cholangitis	0.000388	0.000897	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000386	0.000893	CbGpPWpGaD
Bosutinib—STK4—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000377	0.000872	CbGpPWpGaD
Bosutinib—PHKG1—Disease—NOS2—sclerosing cholangitis	0.000371	0.000859	CbGpPWpGaD
Bosutinib—CSNK1A1—Disease—GOT1—sclerosing cholangitis	0.000349	0.000807	CbGpPWpGaD
Bosutinib—PRKCQ—Disease—GOT1—sclerosing cholangitis	0.000349	0.000807	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—TCF4—sclerosing cholangitis	0.000338	0.000781	CbGpPWpGaD
Bosutinib—CSK—Disease—GOT1—sclerosing cholangitis	0.000337	0.000779	CbGpPWpGaD
Bosutinib—BCR—Disease—HIF1A—sclerosing cholangitis	0.000333	0.00077	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000329	0.000761	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—GOT2—sclerosing cholangitis	0.000327	0.000755	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000323	0.000747	CbGpPWpGaD
Bosutinib—STK3—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000321	0.000742	CbGpPWpGaD
Bosutinib—FGR—Hemostasis—NOS2—sclerosing cholangitis	0.000305	0.000706	CbGpPWpGaD
Bosutinib—BCR—Disease—NOS2—sclerosing cholangitis	0.000303	0.0007	CbGpPWpGaD
Bosutinib—HCK—Disease—GOT2—sclerosing cholangitis	0.0003	0.000693	CbGpPWpGaD
Bosutinib—ERBB4—Disease—GOT2—sclerosing cholangitis	0.000282	0.000653	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—GOT1—sclerosing cholangitis	0.000282	0.000652	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000279	0.000645	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000275	0.000636	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000269	0.000622	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000265	0.000613	CbGpPWpGaD
Bosutinib—HCK—Disease—GOT1—sclerosing cholangitis	0.000259	0.000598	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000255	0.00059	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000255	0.00059	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000255	0.000589	CbGpPWpGaD
Bosutinib—PTK2—Hemostasis—NOS2—sclerosing cholangitis	0.00025	0.000578	CbGpPWpGaD
Bosutinib—ERBB3—Disease—GOT2—sclerosing cholangitis	0.000249	0.000575	CbGpPWpGaD
Bosutinib—YES1—Hemostasis—NOS2—sclerosing cholangitis	0.000247	0.00057	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000246	0.000569	CbGpPWpGaD
Bosutinib—ERBB4—Disease—GOT1—sclerosing cholangitis	0.000244	0.000564	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000243	0.000562	CbGpPWpGaD
Bosutinib—CSNK1A1—Disease—HIF1A—sclerosing cholangitis	0.000243	0.000561	CbGpPWpGaD
Bosutinib—PRKCQ—Disease—HIF1A—sclerosing cholangitis	0.000243	0.000561	CbGpPWpGaD
Bosutinib—CSK—Disease—HIF1A—sclerosing cholangitis	0.000235	0.000542	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000233	0.000539	CbGpPWpGaD
Bosutinib—CSNK1A1—Disease—NOS2—sclerosing cholangitis	0.000221	0.000511	CbGpPWpGaD
Bosutinib—PRKCQ—Disease—NOS2—sclerosing cholangitis	0.000221	0.000511	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000219	0.000506	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000216	0.000499	CbGpPWpGaD
Bosutinib—ERBB3—Disease—GOT1—sclerosing cholangitis	0.000215	0.000497	CbGpPWpGaD
Bosutinib—CSK—Disease—NOS2—sclerosing cholangitis	0.000213	0.000493	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000205	0.000474	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000204	0.000471	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—HIF1A—sclerosing cholangitis	0.000196	0.000454	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000193	0.000446	CbGpPWpGaD
Bosutinib—LYN—Hemostasis—NOS2—sclerosing cholangitis	0.000184	0.000425	CbGpPWpGaD
Bosutinib—ABL1—Hemostasis—NOS2—sclerosing cholangitis	0.000183	0.000423	CbGpPWpGaD
Bosutinib—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	0.000182	0.000421	CbGpPWpGaD
Bosutinib—FYN—Hemostasis—NOS2—sclerosing cholangitis	0.000181	0.000418	CbGpPWpGaD
Bosutinib—HCK—Disease—HIF1A—sclerosing cholangitis	0.00018	0.000416	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—NOS2—sclerosing cholangitis	0.000178	0.000413	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000173	0.000401	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—GOT2—sclerosing cholangitis	0.000171	0.000394	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.00017	0.000393	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—HIF1A—sclerosing cholangitis	0.00017	0.000393	CbGpPWpGaD
Bosutinib—ERBB4—Disease—HIF1A—sclerosing cholangitis	0.00017	0.000392	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000169	0.00039	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—GOT2—sclerosing cholangitis	0.000166	0.000385	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000164	0.00038	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000164	0.00038	CbGpPWpGaD
Bosutinib—HCK—Disease—NOS2—sclerosing cholangitis	0.000164	0.000379	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000161	0.000372	CbGpPWpGaD
Bosutinib—FYN—Disease—GOT2—sclerosing cholangitis	0.00016	0.000371	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—GOT2—sclerosing cholangitis	0.00016	0.000369	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000159	0.000367	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000158	0.000365	CbGpPWpGaD
Bosutinib—ERBB4—Disease—NOS2—sclerosing cholangitis	0.000154	0.000357	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—NOS2—sclerosing cholangitis	0.000151	0.000348	CbGpPWpGaD
Bosutinib—ERBB3—Disease—HIF1A—sclerosing cholangitis	0.000149	0.000346	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—GOT1—sclerosing cholangitis	0.000147	0.00034	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—GOT1—sclerosing cholangitis	0.000144	0.000332	CbGpPWpGaD
Bosutinib—EGFR—Disease—GOT2—sclerosing cholangitis	0.000139	0.00032	CbGpPWpGaD
Bosutinib—FYN—Disease—GOT1—sclerosing cholangitis	0.000138	0.00032	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—GOT1—sclerosing cholangitis	0.000138	0.000318	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000137	0.000318	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000137	0.000317	CbGpPWpGaD
Bosutinib—ERBB3—Disease—NOS2—sclerosing cholangitis	0.000136	0.000314	CbGpPWpGaD
Bosutinib—LCK—Disease—GOT2—sclerosing cholangitis	0.000134	0.000309	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—NOS2—sclerosing cholangitis	0.000133	0.000308	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000132	0.000305	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ABCB4—sclerosing cholangitis	0.000123	0.000285	CbGpPWpGaD
Bosutinib—EGFR—Disease—GOT1—sclerosing cholangitis	0.00012	0.000277	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000119	0.000275	CbGpPWpGaD
Bosutinib—SRC—Disease—GOT2—sclerosing cholangitis	0.000118	0.000273	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000117	0.000271	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000117	0.00027	CbGpPWpGaD
Bosutinib—LCK—Disease—GOT1—sclerosing cholangitis	0.000115	0.000267	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000113	0.000261	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000109	0.000251	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000109	0.000251	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000105	0.000242	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—HIF1A—sclerosing cholangitis	0.000102	0.000237	CbGpPWpGaD
Bosutinib—SRC—Disease—GOT1—sclerosing cholangitis	0.000102	0.000236	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—HIF1A—sclerosing cholangitis	9.99e-05	0.000231	CbGpPWpGaD
Bosutinib—FYN—Disease—HIF1A—sclerosing cholangitis	9.63e-05	0.000223	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—HIF1A—sclerosing cholangitis	9.58e-05	0.000222	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—HIF1A—sclerosing cholangitis	9.32e-05	0.000215	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—NOS2—sclerosing cholangitis	9.31e-05	0.000215	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—HIF1A—sclerosing cholangitis	9.19e-05	0.000212	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—NOS2—sclerosing cholangitis	9.09e-05	0.00021	CbGpPWpGaD
Bosutinib—FYN—Disease—NOS2—sclerosing cholangitis	8.76e-05	0.000203	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—NOS2—sclerosing cholangitis	8.71e-05	0.000202	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—HIF1A—sclerosing cholangitis	8.71e-05	0.000202	CbGpPWpGaD
Bosutinib—EGFR—Disease—HIF1A—sclerosing cholangitis	8.32e-05	0.000192	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—HIF1A—sclerosing cholangitis	8.21e-05	0.00019	CbGpPWpGaD
Bosutinib—LCK—Disease—HIF1A—sclerosing cholangitis	8.02e-05	0.000185	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	7.6e-05	0.000176	CbGpPWpGaD
Bosutinib—EGFR—Disease—NOS2—sclerosing cholangitis	7.57e-05	0.000175	CbGpPWpGaD
Bosutinib—LCK—Disease—NOS2—sclerosing cholangitis	7.29e-05	0.000169	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—HIF1A—sclerosing cholangitis	7.17e-05	0.000166	CbGpPWpGaD
Bosutinib—SRC—Disease—HIF1A—sclerosing cholangitis	7.1e-05	0.000164	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—HIF1A—sclerosing cholangitis	7e-05	0.000162	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—HIF1A—sclerosing cholangitis	6.85e-05	0.000158	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—HIF1A—sclerosing cholangitis	6.74e-05	0.000156	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—HIF1A—sclerosing cholangitis	6.71e-05	0.000155	CbGpPWpGaD
Bosutinib—SRC—Disease—NOS2—sclerosing cholangitis	6.46e-05	0.000149	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GOT2—sclerosing cholangitis	5.86e-05	0.000135	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—HIF1A—sclerosing cholangitis	5.83e-05	0.000135	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—HIF1A—sclerosing cholangitis	5.62e-05	0.00013	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GOT1—sclerosing cholangitis	5.06e-05	0.000117	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GGT1—sclerosing cholangitis	5.06e-05	0.000117	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HIF1A—sclerosing cholangitis	4.97e-05	0.000115	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	3.61e-05	8.34e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	3.11e-05	7.2e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	3.11e-05	7.2e-05	CbGpPWpGaD
